BR0202358A - Stretch Mark Gel - Google Patents
Stretch Mark GelInfo
- Publication number
- BR0202358A BR0202358A BR0202358A BR0202358A BR0202358A BR 0202358 A BR0202358 A BR 0202358A BR 0202358 A BR0202358 A BR 0202358A BR 0202358 A BR0202358 A BR 0202358A BR 0202358 A BR0202358 A BR 0202358A
- Authority
- BR
- Brazil
- Prior art keywords
- gel
- addition
- apply
- bovine bile
- substances
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
"GEL PARA TRATAMENTO DE ESTRIAS". Gel para tratamento de estrias, caracterizada por proporcionar significativo ganho estético com eficácia de maior duração. O referido gel contém em sua composição, além das substâncias comumente utilizadas para este tipo de produto, o extrato de bile bovina, que concentra as propriedades dos ácidos retinóico e glicólico e da vitamina C. Além destas, a bile bovina contém ainda as substâncias colesterol, bilirrubina e ácido cólico, que estimulam a produção de colágeno, responsável por uma eficácia que pode variar de 70% (setenta por cento) a 90% (noventa por cento) na redução das estrias. Modo de uso: aplicar quantidade generosa do gel no local afetado, espalhando uniformemente sobre a pele. Deixar agir por 30 (trinta) minutos e enxaguar abundantemente. Após, aplicar hidratante corporal. Não há contra-indicações."GEL FOR TREATMENT TREATMENT". Stretch mark gel, characterized by providing significant aesthetic gain with longer lasting efficacy. In addition to the substances commonly used for this type of product, this gel contains bovine bile extract, which concentrates the properties of retinoic and glycolic acids and vitamin C. In addition to these, bovine bile also contains cholesterol substances. , bilirubin and colic acid, which stimulate collagen production, responsible for an effectiveness that can range from 70% (seventy percent) to 90% (ninety percent) in reducing stretch marks. How to use: Apply generous amount of gel on the affected area, spreading evenly over the skin. Leave to act for 30 (thirty) minutes and rinse thoroughly. After, apply body moisturizer. There are no contraindications.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR0202358A BR0202358A (en) | 2002-05-27 | 2002-05-27 | Stretch Mark Gel |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR0202358A BR0202358A (en) | 2002-05-27 | 2002-05-27 | Stretch Mark Gel |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0202358A true BR0202358A (en) | 2004-05-04 |
Family
ID=32181103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0202358A BR0202358A (en) | 2002-05-27 | 2002-05-27 | Stretch Mark Gel |
Country Status (1)
Country | Link |
---|---|
BR (1) | BR0202358A (en) |
-
2002
- 2002-05-27 BR BR0202358A patent/BR0202358A/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0015604A (en) | Method for the treatment of hypertrophic scars in order to reduce the size and / or improve their appearance, compositions to treat adverse skin conditions, and, to reduce the size and improve the appearance of hypertrophic scars | |
BR9715022A (en) | Method for treating prostate disease using systematic and / or prolonged release of vitamin D formulations | |
ATE291433T1 (en) | FEMALE EXTRACTS (TANACETUM PARTHENIUM) AGAINST INFLAMMATORY DISEASES | |
BR0013897A (en) | Use of conjugated linoleic acid (cla) or a derivative thereof, topical cosmetic or dermatological composition, and method of treatment and / or prophylaxis of cellulite and fat deposits | |
BR0309890A (en) | Pharmaceutical composition containing blood plasma or blood serum used in the treatment of lesions, as well as its method and application process | |
BRPI0011640B8 (en) | oligosaccharide aldonic acids and their topical use | |
DE60313597D1 (en) | TOPICAL PHARMACEUTICAL COMPOSITIONS WITH PROANTHOCYANIDINES, GLYCYRRHETINIC ACID AND TELEMINE TESTS FOR THE TREATMENT OF DERMATITIS | |
CN105902436A (en) | Acne removal restoring mask applying camellia oleifera seed meal and preparation method thereof | |
BRPI0507895A (en) | composition for the treatment of chronic venous insufficiency, comprising an extract of red vine leaves and an anti-inflammatory agent | |
BR0312232A (en) | Caspase inhibitors and their uses | |
ATE112684T1 (en) | USE OF IGF-II TO TREAT BONE DISEASES. | |
ATE97316T1 (en) | COSMETIC AGENT AND COMPOSITION FOR TREATMENT OF THE SKIN. | |
DK284386D0 (en) | PHARMACEUTICAL PREPARATION FOR SKIN DISORDERS | |
ES2190535T3 (en) | LECTIN COMPOSITIONS AND USE OF THE SAME. | |
ATE353671T1 (en) | USE OF ANABOLICS, ANTI-CATABOLIC AGENTS, ANTIOXIDANTS AND ANALGESICS FOR THE PROTECTION, TREATMENT AND REPAIR OF CONNECTIVE TISSUES IN HUMAN AND ANIMALS | |
BRPI0415781A (en) | Method for treating diabetes in a patient and pharmaceutical kit | |
BR0111506A (en) | Macromolecular drug complexes and compositions containing same | |
BR0111158A (en) | Compound and physiological salts thereof, method for treating a median condition by tnf-a in a patient | |
HUP0304077A2 (en) | Pharmaceutical and cosmetic compositions against skin aging | |
CN107308028A (en) | Cutaneous penetration essence | |
BR0202358A (en) | Stretch Mark Gel | |
BR0109148A (en) | Methods for increasing intestinal absorption of a fat-soluble vitamin in a postmenopausal woman, for increasing bile secretion of a fat-soluble vitamin in a postmenopausal woman, for increasing the liver concentration of a fat-soluble vitamin in a postmenopausal woman to reduce the risk of one or more diseases in a postmenopausal woman and to reduce the risk of one or more diseases in an animal | |
BRPI0417692A (en) | use of a composition, method of reducing the effects of psychologically mediated stress on the skin of a human or animal, composition, nutritional supplement, cosmetic composition, and method for identifying a compound capable of reducing the effects and method of producing a composition. for reducing the effects of psychologically mediated stress on the skin of a human or animal | |
BR0308517A (en) | Combination of an aldosterone receptor antagonist and bile acid sequestering agent | |
US20140030365A1 (en) | Compositions for the debridement, granulation and reepithelialization of wounds in man |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: PAGAR RESTAURACAO. |
|
B08H | Application fees: decision cancelled |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2258 DE 15/04/2014. |
|
B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
B09B | Decision: refusal |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8 E 13 DA LPI |
|
B09B | Decision: refusal |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |